Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Other Operating Expenses (2020 - 2025)

Rapid Micro Biosystems' Other Operating Expenses history spans 6 years, with the latest figure at $10.0 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 3.1% year-over-year to $10.0 million; the TTM value through Sep 2025 reached $39.9 million, down 2.37%, while the annual FY2024 figure was $41.4 million, 0.24% changed from the prior year.
  • Other Operating Expenses for Q3 2025 was $10.0 million at Rapid Micro Biosystems, down from $10.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $11.5 million in Q3 2022 and bottomed at $8.6 million in Q2 2022.
  • The 5-year median for Other Operating Expenses is $10.3 million (2023), against an average of $10.3 million.
  • The largest annual shift saw Other Operating Expenses soared 39.89% in 2021 before it dropped 22.35% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $11.1 million in 2021, then decreased by 0.45% to $11.1 million in 2022, then fell by 12.88% to $9.7 million in 2023, then rose by 5.68% to $10.2 million in 2024, then fell by 1.78% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Other Operating Expenses are $10.0 million (Q3 2025), $10.1 million (Q2 2025), and $9.6 million (Q1 2025).